Orano Med

Innovative targeted alpha therapy using lead-212 (Pb-212) against cancer.

[Molecular Partners @MolecularPrtnrs]

We have today expanded our strategic collaboration with Orano Med – it now includes the co-development of an additional six targeted alpha therapeutics candidates.

👉 https://t.co/tUcXCHGPrV

#oncology #cancer #cancerresearch #immunooncology #partnership

[Orano Med @OranoMed]

🤝 Last week, we announced an expanded partnership with @MolecularPrtnrs, adding the development of six new targeted alpha therapeutic candidates to our pipeline - bringing the total to ten programs between the two companies.

Read the Press Release: https://t.co/NoKlXwNJ0M

[Préfet de la Haute-Vienne @Prefet87]

#France2030 | 🧑🏻‍🔬 Hier, Françoise Slinger-Cecotti, sous-préfète de #Bellac, a posé la première pierre de l'Advanced Thorium Extraction Facility (#ATEF), à Bessines-sur-Gartempe, en présence d'Andréa Brouille, première vice-présidente de la région Nouvelle-Aquitaine, de Claude Imauven, président du conseil d’administration d’Orano et de Julien Dodet, président du conseil de gouvernance d'Orano Med.

👏🏻 Unique au monde, ce projet est mené par @Oranogroup pour produire du thorium-228, précurseur du plomb-212, utilisé en radiothérapie ciblée contre le cancer, notamment pour les patients en impasse thérapeutique.

👉 Lauréat du plan France 2030, @OranoMed bénéficie de plus de 22 millions d’euros d’aides de l’État, symbole de la volonté du gouvernement d'encourager et d'accompagner l'#Innovation sur l'ensemble du territoire national.

[Orano Med @OranoMed]

#OranoMed reaches a significant milestone at #BessinesSurGartempe with the groundbreaking of ATEF, the first facility dedicated to the industrial-scale production of thorium-228, a precursor of lead-212. #RLT
To learn more ➡️ https://t.co/s1qzMhc62X

[Orano Group @Oranogroup]

[CP] @sanofi et @OranoMed unissent leurs forces pour développer des #radiothérapies internes vectorisées de nouvelle génération 👉 https://t.co/4pcSAgMM3d

[Orano Med @OranoMed]

Nous sommes ravis d’annoncer la #signature d’un accord d’investissement de @Sanofi dans nos activités de biotechnologies, avec une participation de 16% environ pour 300 millions d’euros. 🎉

Pour en savoir plus 👉 https://t.co/wmh034YXhx

[Orano U.S. @Orano_usa]

Ready to talk about careers in nuclear medicine production and delivery in the fight against cancer? Our @OranoMed team is recruiting at Purdue University today! #OranoHires @purduewin @purduenuclear @NuclearPurdue
https://t.co/oBuHGJqxyf

[BiotechTV @BiotechTV]

From Zurich: The CEO of @OranoMed gives an overview of the radiopharmaceutical approach and why he believes alpha emitters are the way to go.

Full video: https://t.co/Hudgad3bcD

[Orano Group @Oranogroup]

[PR] Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
👉https://t.co/SEkFG9iPaQ

[Orano Med @OranoMed]

🚀 Exciting news! #OranoMed has signed an exclusive licensing agreement with @sanofi for the commercialization of our most advanced treatment, AlphaMedix™, developed with @RadioMedix. A major step toward bringing this therapy to patients worldwide! 🌍

➡️ https://t.co/ucj1pEuYWU

[Orano Med @OranoMed]

We are hiring in the US!

- Executive assistant
- Purchasing agent
- HR generalist
- Laboratory instrument repair/calibration
- QA specialist
- QC analyst
- Manufacturing technician
- Head of regulatory affairs
- IS/IT/Helpdesk

Send your resume to [email protected].

[Orano Med @OranoMed]

Proud of the important steps taken by Orano Med! https://t.co/QPMr7k9COg

[Orano Med @OranoMed]

@OranoMed is proud to inaugurate extension of the Maurice Tubiana Laboratory and its new Research & Development Center in Bessines-France, for the manufacturing of Lead-212 #Plomb212, used for the development of Targeted Alpha Thérapies against #cancer.

[Orano Group @Oranogroup]

📸@OranoMed est fier d'inaugurer à Bessines (87), l’extension du Labo. M. Tubiana & son Centre #RetD dédié à la fabrication du #Plomb212, élément radioactif rare utilisé pr le dév. de traitements innovants contre le #cancer. 🔬
Cc. Pascale Rodrigo; @AndreaBrouille; @ClaudeImauven

[Orano EU @Orano_euoffice]

Interesting joint paper by @FORATOM_nuclear and Nuclear Medicine Europe. Nuclear has an important role to play in medicine: @Oranogroup, through its subsidiary @OranoMed, is committed to accelerate development of therapies and to supply treatment against cancer #CancerResearch

[Orano Med @OranoMed]

HIRING: Join our team! We are seeking a Head of Production Unit in Brownsburg, IN. See details and application: https://t.co/liPATWrfQg

[Orano Med @OranoMed]

Join our Chief Medical Officer, Jason D. Hurt, MD, at the Targeted Radiopharmaceuticals 2020 Summit as he discusses conducting clinical oncology trials with radiopharmaceuticals. #radiopharma #oncology

[Orano Med @OranoMed]

HIRING: Join our team! We are seeking a Senior Manager, QA/QC in Plano, TX. See Indeed for details and application: https://t.co/SLTeHi8iqJ

[Orano Med @OranoMed]

Orano Med increases its capacity for the production of Lead-212 for the development of cancer treatments. https://t.co/zgm7du5GIY

[Orano Med @OranoMed]

If you are near Marseille October 3-5, come and support the #OranoMed crew in the Neptunium 2019 sailing race. Good luck to our team!